Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$444,988
+$175,496 QoQ
Shares Held
371
+26.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3,844
of 4,605 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essential Partners LLC holds $4,144,626 across 14 Drug Manufacturers - General names. LLY ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,044 | $1,290,654 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
17,545 | $1,010,942 | |
| 3 | JNJ |
Johnson & Johnson
|
2,596 | $659,306 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
371 | $444,988 | |
| 5 | BIIB |
Biogen Inc.
|
1,355 | $292,761 | |
| 6 | PFE |
Pfizer Inc
|
10,101 | $243,232 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
515 | $65,065 | |
| 8 | NVS |
Novartis AG
|
320 | $50,150 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $444,988 | 371 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $269,492 | 293 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $238,578 | 222 | Shares | Sole | 2026-05-21 | |
| 2025-09-30 | $138,103 | 181 | Shares | Sole | 2026-05-21 | |
| 2025-06-30 | $74,055 | 95 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||